112
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Interprofessional Medication Self-Management Program for Older Underserved Adults

, ORCID Icon, &
Pages 839-845 | Published online: 18 May 2020

References

  • Ritchey M, Chang A, Powers C, et al. Vital signs: disparities in antihypertensive medication nonadherence among medicare part D beneficiaries – United States. MMWR Morb Mortal Wkly Rep. 2014;65:967–976. doi:10.15585/mmwr.mm6536e1
  • National Committee for Quality Assurance. Comprehensive diabetes care. Report Cards. 2017. Available from: http://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality/2017-table-of-contents/diabetes-care. Accessed April 4, 2020.
  • Freid VM, Berstein AB, Bush MA. Multiple chronic conditions among adults aged 45 and over: trends over the past 10 years. Centers Dis Control Prev Nat Center Health Stat. 2012. Available from: https://www.cdc.gov/nchs/data/databriefs/db100.pdf. Accessed April 4, 2020.
  • Kalyani RR, Golden SH, Cefalu WT. Diabetes and aging: unique considerations and goals of care. Diabetes Care. 2017;40(4):440–443. doi:10.2337/dci17-0005
  • Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2016;296(21):2563–2571. doi:10.1001/jama.296.21.joc60162
  • Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–314. doi:10.4065/mcp.2010.0575
  • Marek KD, Stetzer F, Adams SJ, Kelly L. Cost utility analysis of a home-based nurse care coordination program. Nursing Eco. 2018;36(2):83–87.
  • Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–312. doi:10.1345/aph.1D252
  • Sleeper RB. Challenges in geriatric care. In: Fundamentals of Geriatric Pharmacotherapy [edited by Lisa C. Hutchins], 2nd ed. Bethesda, MC: ASHP Publications; 2015:15.
  • Obreli-Neto PR, Marusic S, de Lyra Junior DP, et al. Effect of a 36-month pharmaceutical care program on coronary heart disease risk in elderly diabetic and hypertensive patients. J Pharm Pharmaceut Sci. 2011;14(2):249–263. doi:10.18433/J3259Q
  • Obreli-Neto PR, Guidoni CM, de Oliveira Baldoni A, et al. Effect of a 36-month pharmaceutical care program on pharmacotherapy adherence in elderly diabetic and hypertensive patients. Int J Clin Pharm. 2011;33:642–649. doi:10.1007/s11096-011-9518-x
  • Nurses Improving Care for Healthsystem Elders (NICHE). 2018. Available from: http://www.nicheprogram.org/. Accessed April 4, 2020.
  • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):E1–E14.
  • American Diabetes Association Standards of Medical Care in Diabetes. Older adults. Diabetes Care. 2016; 39 (Suppl. 1): S81–S85.
  • Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71:e127–e248. doi:10.1016/j.jacc.2017.11.006
  • Pharmacy Quality Alliance. Update on medication quality measures in medicare part D plan star ratings-2018. PQA Measures. 2018. Available from: http://pqaalliance.org/measures/cms.asp. Accessed April 4, 2020.
  • Joszt L. Five vulnerable populations in healthcare. Am J Manag Care. 2018. Available from: https://www.ajmc.com/newsroom/5-vulnerable-populations-in-healthcare. Accessed April 04, 2019.
  • Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
  • Tuomilehto J, Rastenyte D, Birkenhäger WH, et al. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med. 1999;340(9):677–684. doi:10.1056/NEJM199903043400902
  • Stratton IM, Adler AI, Neil AW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–412. doi:10.1136/bmj.321.7258.405